UFP Technologies Announces Strong Q3 Results
Key Highlights
- ➤Q3 sales $172.4M, up 11.6% year over year
- ➤Q3 net income $20.6M, up 25.8% year over year
- ➤Q3 adjusted EPS $2.88, versus $2.39 in 2025
- ➤Q3 gross margin increased to 29.4% from 27.7%
- ➤UFP pursuing acquisitions and expanding its credit facility
Expert Statements
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“Our third quarter and year-to-date results reflect continued solid execution across the UFP platform and progress toward our long-term growth strategy.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“In the third quarter, sales grew 11.6%, including 11.1% organic growth, gross margins increased to 29.4%, and adjusted operating income grew 14.5%.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“MedTech sales grew 12.5%, reflecting broad-based demand across our portfolio.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“Year-to-date sales increased 10.3% to $500.6 million.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“MedTech sales grew 11.7% and our top five MedTech customers collectively grew 11.7%, reinforcing the balance, diversity, and durability of our portfolio of operating businesses.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“Operationally, we are seeing meaningful improvements across our businesses, including scaling new programs in the Dominican Republic and margin improvements in our legacy UFP operations.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“Our 2025 investment in TPI has exceeded our expectations and provides an initial position in injection molding, a technology where we see opportunity to expand across UFP.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“However, scheduled program transfers to the Dominican Republic and margin improvement remain behind plan.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“Looking ahead to 2027, we are optimistic about the strength and positioning of UFP.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“We have invested in additional capacity at DAS Medical to support double-digit growth and have continued to build and invest in the team.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“We also continue to see attractive acquisition opportunities and are making progress on several of them.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“In parallel, we are working to expand our credit facility, increasing our capacity to invest in high-quality businesses that meet our investment criteria.”
Mitch Rock, President and Chief Executive Officer of UFP Technologies
“With a strong balance sheet and an expanded team, we have the capacity to effectively onboard larger businesses and create long-term value.”
UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.6 million for its third quarter ended September 30, 2026, 25.8% higher than net income of $16.4 million for the third quarter of 2025. Net sales for the quarter ended September 30, 2026 were $172.4 million, 11.6% higher than 2025 third quarter sales of $154.6 million. Generally accepted accounting principles ("GAAP") and adjusted earnings per diluted common share outstanding ("EPS") for the quarter ended September 30, 2026 were $2.64 and $2.88, respectively. Net income for the nine-month period ended September 30, 2026 was $59.0 million, 16.2% higher than net income of $50.7 million for the same period in 2025. Net sales for the nine-month period ended September 30, 2026 were $500.6 million, compared to sales of $453.9 million in the same period of 2025. GAAP and adjusted EPS for the nine-month period ended September 30, 2026 were $7.56 and $8.28, respectively.
Get started
Create a free account to read the full story.